Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder (ACCEPTANCE)
Status
Conditions
Treatments
Details and patient eligibility
About
The study is designed to demonstrate that treatment with low level stimulation of the bladder muscles reduces symptoms of urinary incontinence in comparison with no stimulation.
Full description
The Medtronic InterStim device delivers stimulation therapy for the treatment of chronic intractable (functional) disorders of the pelvis and lower urinary or intestinal tract through the sacral nerve or the pudendal nerve systems.
This trial is designed to demonstrate that neuromodulation of the pudendal nerve will effectively treat patients with neurogenic overactive bladder. Symptoms of urinary incontinence are compared when stimulation is switched on for 4 weeks to stimulation switched off for 4 weeks. After the eight week crossover period, all patients receive treatment and are followed up within the study for 12 months post implant.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Incomplete upper motor neuron lesion
- Detrusor overactivity
- Two leaks or two notices of leaks per day
- Mean functional bladder capacity (volume voided per episode) of ≥100 ml
Exclusion criteria
- Complete spinal lesion or complete bilateral lesion of sacral / pudendal nerves.
- Degenerative disease of the central nervous system
Trial design
Primary purpose
Allocation
Interventional model
Masking
17 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal